Circle Pharma Announces Appointment of David Spellmeyer, PhD, as Chief Scientific Officer Epsilon09242023-07-19T07:10:34-07:00November 20, 2017|Press Releases|
Practical Medicinal Chemistry with Macrocycles – Design, Synthesis, and Case Studies Epsilon09242017-10-18T17:53:45-07:00October 18, 2017|Publications|
Discovery of potent and orally bioavailable macrocyclic peptide-peptoid hybrid CXCR7 modulators. Epsilon09242017-10-18T10:00:18-07:00October 18, 2017|Publications|
Cyclic peptide natural products chart the frontier of oral bioavailability in the pursuit of undruggable targets Epsilon09242017-05-29T18:07:39-07:00May 29, 2017|Publications|
Circle Pharma announces expansion of Series A financing and appointment of James C. Lu to its board Epsilon09242023-07-19T07:11:03-07:00April 25, 2017|Press Releases|
Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules Epsilon09242017-01-06T11:00:02-08:00January 6, 2017|Publications|
Circle Pharma announces Series A financing and appoints Walter H. Moos, Ph.D., to its board Epsilon09242023-07-19T07:11:27-07:00December 21, 2016|Press Releases|
Passive Membrane Permeability in Cyclic Peptomer Scaffolds Is Robust to Extensive Variation in Side Chain Functionality and Backbone Geometry Epsilon09242016-10-03T11:40:24-07:00October 3, 2016|Publications|
Circle Pharma enters into an agreement with Pfizer to build screening library of macrocyclic peptides Epsilon09242023-07-19T07:12:00-07:00September 12, 2016|Press Releases|
Stereochemistry Balances Cell Permeability and Solubility in the Naturally Derived Phepropeptin Cyclic Peptides Epsilon09242016-06-06T11:00:20-07:00June 6, 2016|Publications|